How Lupron Treats Prostate Cancer
Lupron (leuprolide acetate) is an injectable hormone therapy that lowers testosterone levels to slow prostate cancer growth. Prostate cancer cells often rely on testosterone (androgens) to multiply, so Lupron suppresses this hormone, shrinking tumors and easing symptoms.[1]
Doctors administer it via subcutaneous or intramuscular injections, typically every 1, 3, 4, or 6 months, depending on the formulation (e.g., Lupron Depot). Treatment starts with a loading dose and continues long-term, often combined with radiation or surgery.[1][2]
When Do Doctors Prescribe It?
Lupron serves as:
- Primary hormone therapy for advanced or metastatic prostate cancer.
- Neoadjuvant therapy before radiation to boost effectiveness.
- Adjuvant therapy after surgery or radiation to prevent recurrence.
- Palliative care to manage symptoms in late-stage disease.
Guidelines from the National Comprehensive Cancer Network (NCCN) recommend it for high-risk cases or when cancer has spread.[2][3]
How It Works Step by Step
Lupron is a gonadotropin-releasing hormone (GnRH) agonist. It initially spikes luteinizing hormone (LH) and follicle-stimulating hormone (FSH), raising testosterone briefly ("flare" effect, managed with anti-androgens like bicalutamide). Over 2-4 weeks, it desensitizes pituitary receptors, slashing LH/FSH and dropping testosterone by 95% within a month—mimicking medical castration.[1][4]
Blood tests confirm castrate-level testosterone (<50 ng/dL) after 4 weeks.[3]
Dosage and Administration Options
| Formulation | Dose | Dosing Interval | Typical Use |
|-------------|------|-----------------|-------------|
| Lupron Depot 7.5 mg | 7.5 mg | Every month | Short-term or initial therapy |
| Lupron Depot 22.5 mg | 22.5 mg | Every 3 months | Maintenance |
| Lupron Depot 30 mg | 30 mg | Every 4 months | Convenience-focused |
| Lupron Depot 45 mg | 45 mg | Every 6 months | Long-term advanced cases[1] |
Self-injection kits exist for some patients; clinics handle most.[2]
Common Side Effects and Management
Testosterone suppression causes:
- Hot flashes (50-80% of patients).
- Fatigue, erectile dysfunction, reduced libido.
- Bone loss (monitor with DEXA scans; add bisphosphonates if needed).
- Injection-site reactions, weight gain.
The initial flare risks temporary tumor growth or urinary issues—prevent with short-term anti-androgens. Long-term use raises cardiovascular and diabetes risks; regular monitoring is standard.[1][4]
How It Compares to Other Hormone Therapies
| Therapy | Type | Key Difference from Lupron |
|---------|------|----------------------------|
| Zoladex (goserelin) | GnRH agonist | Similar efficacy; implant every 1-3 months |
| Firmagon (degarelix) | GnRH antagonist | No flare; monthly injections, faster onset |
| Xtandi (enzalutamide) or Zytiga (abiraterone) | Androgen receptor inhibitors | Used after Lupron failure; oral, targets resistant cancers |
| Orchiectomy | Surgical castration | Permanent; no injections needed[3][5] |
Lupron matches agonists in survival rates but costs more upfront ($500-2,000 per dose, insurance-covered).[6]
Treatment Duration and Monitoring
- 6-36 months for localized high-risk cancer with radiation.
- Indefinite for metastatic disease until progression.
PSA levels drop 90%+ in responders; rise signals resistance (switch to second-line therapies).[2][3]
Who Makes Lupron and Access Issues
AbbVie manufactures Lupron Depot under license from Takeda. Patents protect formulations until 2025-2030 for extended-release versions—check DrugPatentWatch.com for expiry details and generics.[7]
Patient assistance programs from AbbVie cover copays for eligible uninsured/low-income individuals.[6]
Sources
[1] Lupron.com prescribing information
[2] NCCN Prostate Cancer Guidelines v.3.2024
[3] American Urological Association Guidelines
[4] PubMed: Mechanism of GnRH agonists
[5] ASCO: Hormone Therapy Comparison
[6] GoodRx Lupron Pricing
[7] DrugPatentWatch.com: Leuprolide Patents